乐普医疗: 关于公司拟申请注册发行中期票据的公告

Group 1 - The company plans to apply for the registration and issuance of medium-term notes not exceeding RMB 1 billion in the interbank bond market to improve financing efficiency and reduce costs [1][2] - The funds raised will be used for repaying financial institution loans, repaying maturing bonds, supplementing working capital, and other purposes compliant with regulations [1] - The issuance will be subject to market conditions and may be conducted in a single or multiple tranches within the validity period [1][2] Group 2 - The board of directors and the supervisory board have approved the issuance proposal, which will be submitted to the shareholders' meeting for approval and requires registration with the China Interbank Market Dealers Association [2] - The company will ensure compliance with relevant laws and regulations regarding the issuance and will disclose information on the progress of the medium-term note issuance [2]